期刊文献+

血清胱抑素C对2型糖尿病患者肾脏损伤早期预警能力的研究 被引量:4

下载PDF
导出
摘要 目的探讨血清胱抑素C(Cys C)检测能否作为糖尿病患者糖尿病肾病早期检测指标。方法选择血压小于130/80mm Hg,尿清蛋白大于或等于30mg/gCr且小于300mg/gCr,肾小球滤过率(eGFR)>90mL/min的患者共135例。比较血清Cys C、尿清蛋白和eGFR之间的相关性,计算血清Cys C在该患者群的阳性率。结果该患者群中血清Cys C高于正常上限的占5.2%;低于正常下限的占3.7%。血清Cys C与尿清蛋白和eGFR结果间不存在相关性,R2分别为0.002 5和0.016 0。结论血清Cys C的诊断灵敏度不足以提示糖尿病患者的早期肾脏损伤。
出处 《国际检验医学杂志》 CAS 2014年第5期626-627,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献12

  • 1Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate[J]. Ann Intern Med, 2006,145(4) :247-254.
  • 2Grubb A, Simonsen O, Sturfelt G, et al. Serum concentration of cystatin C,faetor D and beta 2-microglobulin as a measure of glo merular filtration rate[J]. Acta Med Scand, 1985,218 (5) : 499- 503.
  • 3Newman DJ,Thakkar H, Edwards RG,et al. Serum cystatin C:areplacement {or creatinine as a biochemical marker o{ GFR[J]. Kidney Int Suppl,1994,47(1) 20 21.
  • 4Herget Rosenthal S,Trabold S, Pietruck F, et al. Cystatin C: effi cacy as screening test for reduced glomerular filtration rate[J]. Am J Nephrol,2000,20(2) :97 102.
  • 5Meier P, Froidevaux C, Dayer E, et al. Cystatin C concentration and glomerular filtration rate[J]. Lancet, 2001,357 (9256) 634 635.
  • 6Finney H, Newman DJ, Thakkar H, et al. Reference ranges for plasma cystatin C and ereatinine measurements in premature in- fants,neonates,and older children[J]. Arch Dis Child, 2000,82 (1):71-75.
  • 7Patterson WP, Reams GP. Renal toxieities of ehemotherapy[J]. Semin Oneol, 1992,19(5) : 521-528.
  • 8Le Bricon T, Thervet E, Froissart M, et al. Plasma cystatin C is superior to 24 h creatinine clearance and plasma creatinine for es timation of glomerular filtration rate 3 months after kidney trans- plantation[J]. Clin Chem,2000,46(8 Pt 1) :1206-1207.
  • 9Woitas RP, Stoffel Wagner B, Flommersfeld S, et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis[J]. Clin Chem,2000,46(5) :712 715.
  • 10Tomino Y,Suzuki S,(;ohda T,et al. Serum cystatin C May predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy[J]. J Clin Lab Anal, 2001,15 (1) : 25 29.

二级参考文献11

共引文献26

同被引文献26

  • 1张新春,陈涛.尿微量白蛋白测定在高血压早期肾损害诊断中的临床应用[J].检验医学与临床,2006,3(1):25-26. 被引量:13
  • 2Stevens LA,Coresh J,Schmid CH,et al.Estimating GFR using sernm cystatin C alone and in combination with serum creatinine:a pooled analysis of 3,418 individuals with CKD[J].Am J Kidney Dis,2014,51(12):395-406.
  • 3Blaufox MD,Aure]l M,Bubeck B,el al.Report of the Radionuclides in Nephrourology Committee on renal clearance[J].J Nucl Med,2015,37(20):1883-1890.
  • 4Myers GL,Miller WG,Coresh J,et al.Recommenda Iions for improving seram creatiine measurement:a report from the Laboratory Working Group of the National Kidney Disease Education Programf[J].Clin Chem.2014,52(14):5-18.
  • 5Trimarchi H,Muryan A,Martino D,et al.Creatinine-VS.cystatin C-based equations compared with 99m Tc DTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease[J].J Nephrol,2012,25(26):1003-1015.
  • 6Inker LA,Schmid CH,Tighiouart H,et al.Estimating glomer ular filtration rate from serum creatinine and cystatin C[J].N Engl J Med,2012,367(5):20-29.
  • 7Peraha CA,Shlipak MG,Judd S,et al.Detection of chronic kidney disease with creatinine,cystatin C,and urine albumin-tocreatinine ratio and association with progression to end-stage renal disease and mortality[J].JAMA,2014,305(16):1545-1552.
  • 8Ireland R.Chronic kidney disease:Use of urine albumin and cystatin C levels improves risk stratification in chronic kidney disease[J].Nat Rev Nephrol,2013,7(15):301.
  • 9蒋亚萍.妊娠高血压综合征患者血清胱抑素C测定的临床意义[J].检验医学与临床,2008,5(7):432-433. 被引量:15
  • 10梁宁,郑青,陈夏明.原发性高血压肾病患者血清胱抑素C和尿微量白蛋白检测的临床意义[J].标记免疫分析与临床,2009,16(6):342-343. 被引量:9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部